GLIAPHARM Trademark

Trademark Overview


On Thursday, December 29, 2016, a trademark application was filed for GLIAPHARM with the United States Patent and Trademark Office. The USPTO has given the GLIAPHARM trademark a serial number of 79205568. The federal status of this trademark filing is REGISTERED as of Tuesday, October 3, 2017. This trademark is owned by Gliapharm SA. The GLIAPHARM trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological preparations for the prevention and treatment of neurological diseases; pharmaceutical preparations for the prevention and treatment of neurological diseases; chemical preparations for the prevention and treatment of neurological diseases; pharmaceutical products for the prevention and treatment of neurological diseases; medicines for the prevention and treatment of neurological diseases; diagnostic preparations for medical use; biomarking diagnostic reagents for medical use; plant extracts for pharmaceutical use

Clinical trials, scientific laboratory services, biological research, scientific research, research and development of new products for others, chemical research
gliapharm

General Information


Serial Number79205568
Word MarkGLIAPHARM
Filing DateThursday, December 29, 2016
Status700 - REGISTERED
Status DateTuesday, October 3, 2017
Registration Number5298874
Registration DateTuesday, October 3, 2017
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 18, 2017

Trademark Statements


Description of MarkThe mark consists of two intersecting circles with a continual line running through both circles. The lighter shaded circle stands on the right and upper side, while the darker shaded circle stands on the left and lower side. The lighter shaded circle has a line crossing through the center of the continual line. The darker shaded circle adds an additional line to create a checkmark design at the bottom of the continual line. The stylized wording "GLIAPHARM" is shown underneath the circles, with the element "GLIA" appearing in a darker shade.
Goods and ServicesBiological preparations for the prevention and treatment of neurological diseases; pharmaceutical preparations for the prevention and treatment of neurological diseases; chemical preparations for the prevention and treatment of neurological diseases; pharmaceutical products for the prevention and treatment of neurological diseases; medicines for the prevention and treatment of neurological diseases; diagnostic preparations for medical use; biomarking diagnostic reagents for medical use; plant extracts for pharmaceutical use
Pseudo MarkGLIA PHARM
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesClinical trials, scientific laboratory services, biological research, scientific research, research and development of new products for others, chemical research

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 27, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGliapharm SA
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Party NameGliapharm SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Party NameGliapharm SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, April 2, 2024TEAS SECTION 71 & 15 RECEIVED
Monday, October 3, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, February 16, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 18, 2018FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 18, 2018FINAL DISPOSITION PROCESSED
Wednesday, January 3, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 3, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, July 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 6, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, June 6, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 6, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, June 6, 2017EXAMINERS AMENDMENT -WRITTEN
Saturday, June 3, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 2, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 2, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 27, 2017REFUSAL PROCESSED BY IB
Thursday, May 11, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 11, 2017REFUSAL PROCESSED BY MPU
Saturday, May 6, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 5, 2017NON-FINAL ACTION WRITTEN
Tuesday, May 2, 2017APPLICATION FILING RECEIPT MAILED
Friday, April 28, 2017ASSIGNED TO EXAMINER
Thursday, April 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 20, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB